Hints and tips:
Showing results for Zydus Pharma-Ceuticals (USA), Inc.
...In particular, WBA pointed to a 2.3 per cent year-on-year rise in sales at its main Retail Pharmacy USA division, with a rise in pharmacy sales offsetting declining retail sales....
...Our 10% WACC remains a premium to our mid-cap pharma peer average 8.6% which reflects our view of increased risk around single product execution....
...Campari will be hard hit by COVID-19 due to high On Trade exposure, especially in core markets of Italy and the USA....
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
...In April last year Fresenius, a large German medical products group, announced an acquisition of American generics pharma company Akorn for nearly $5bn....
...Zydus Pharmacuticuals (USA), Inc....
.... ———- Chartwatch Drug donations Pharma companies provide more than 1.8bn treatments a year for neglected tropical diseases....
...The move quickly spurred market speculation that Mr Son would revive talks for a merger between SoftBank-owned Sprint and rival T-Mobile USA....
...Drug price scandal alters outlook for biotech groups Tens of billions of dollars were wiped off the value of biotech and pharmaceuticals companies this week after Hillary Clinton pledged to tackle “profiteering...
...The chief executive of pharmaceuticals company Actavis had taken to the stage to address the salesforce at Allergan, one of his first big outings after his group had said it would buy the maker of injectable...
...KKR will acquire the minority stake in Gland Pharma, including the entire stake held by private equity fund, Evolvence India Life science Fund, in the Hyderabad-based firm, KKR said in a statement.”...
...Related reading: Ranbaxy: losses, again, beyondbrics India pharma: Strides Arcolab in $1.6bn deal with US generics maker Mylan, beyondbrics India: pharma companies sales to suffer on new round of price controls...
...Nestlé is not the first to face this sort of problem – razor makers, printer manufacturers and pharma companies all like to tie customers in to buying their consumables, but face competition from generic...
...The scale of the new group and the restructuring it will trigger are likely to spark other pharmaceuticals mergers and acquisitions that have been held back while waiting for Pfizer....
...David Drane, Dorset Tim Price: The gloom in relation to US Inc is probably overdone....
...Larry Lynch, USA Tom Glocer: I think there’s always going to be a role for newspapers....
...A patient selecting ‘diabetes’, then ‘USA’ would find himself at the Keeping well with Diabetes site (www.kwwd.com ), which cheerfully offers a $25 rebate on NovoLog Mix 70/30....
International Edition